Orexo AB Appoints Robert A. DeLuca as President of Orexo US Inc.
7/1/2013 7:45:30 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Uppsala, Sweden - July 1, 2013 – Orexo AB announces today that it has appointed
Robert A. DeLuca, as President of Orexo US Inc., a fully owned US subsidiary of
Orexo AB. Orexo US Inc will focus on commercialization of Zubsolv™
(buprenorphine and naloxone, sublingual tablets) in collaboration with the
appointed partner Publicis Touchpoint Solutions. With the establishment of a
commercial leadership team in the US, Orexo AB in Sweden will focus its
resources on the development of new products including product extensions of
Zubsolv, manufacturing and quality assurance and provide overall corporate
governance. Mr. DeLuca will become a member of the Executive Management team of
Help employers find you! Check out all the jobs and post your resume.